title: Hypertension and pregnancy: expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology.
abstract: High blood pressure in pregnancy remains, by its complications, the leading cause of morbidity as well as maternal and fetal mortality. The frequency (5-10% of pregnancies) and the potential severity of this disease, for both mother and child, encourage to standardize and to optimize our medical practices. If the short-term complications for the mother and child are well known, long-term ones for the mother are beginning to be better identified. The onset of hypertension during pregnancy disrupts the classic organization of health care and requires the intervention of the general practitioner and/or an obstetrician, a gynecologist, a midwife, a cardiologist, a nephrologist. There is not always a care coordinator, and decisions are sometimes taken with delay. This is what drove the French Society of Hypertension, in partnership with the French National College of Gynecologists-Obstetricians, to develop a consensus proposing easy-to-use guidelines. Educating women and all health professionals to hypertension and its management, in line with current scientific data, is one of the major challenges of this consensus.
authors.affiliation: French Society of Hypertension, 5 rue des Colonnes du Trône, 75012, Paris, France.
authors.forename: Claire
authors.initials: C
authors.lastname: Mounier-Vehier
authors.affiliation: French Society of Hypertension, 5 rue des Colonnes du Trône, 75012, Paris, France.
authors.forename: Jacques
authors.initials: J
authors.lastname: Amar
authors.affiliation: French Society of Hypertension, 5 rue des Colonnes du Trône, 75012, Paris, France.
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Boivin
authors.affiliation: French Society of Hypertension, 5 rue des Colonnes du Trône, 75012, Paris, France.
authors.forename: Thierry
authors.initials: T
authors.lastname: Denolle
authors.affiliation: French Society of Hypertension, 5 rue des Colonnes du Trône, 75012, Paris, France.
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Fauvel
authors.affiliation: College of Medical Gynecology Teachers, Hôpital Port-Royal, Unité de Gynécologie médicale, 123 boulevard Port-Royal, 75014, Paris, France.
authors.forename: Geneviève
authors.initials: G
authors.lastname: Plu-Bureau
authors.affiliation: French National College of Gynecologists-Obstetricians, 91 Boulevard de Sébastopol, 75002, Paris, France.
authors.forename: Vassilis
authors.initials: V
authors.lastname: Tsatsaris
authors.affiliation: French Society of Hypertension, 5 rue des Colonnes du Trône, 75012, Paris, France.
authors.forename: Jacques
authors.initials: J
authors.lastname: Blacher
mesh_terms: D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D018660:Blood Pressure Monitoring, Ambulatory / Q000379:methods; D002908:Chronic Disease; D005260:Female; D005602:France; D006801:Humans; D046110:Hypertension, Pregnancy-Induced / Q000175:diagnosis* / Q000628:therapy*; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D012955:Societies, Medical
chemical_list: D000959:Antihypertensive Agents
keywords: blood pressure measurement; cardiovascular risk; general practitioner; hypertension; preeclampsia; treatment